Skip to main content
M

MEMPHASYS LIMITED. — Investor Relations & Filings

Ticker · MEM ISIN · AU000000MEM5 LEI · 549300RZ3LBXHF3WXL97 ASX Professional, scientific and technical activities
Filings indexed 1,181 across all filing types
Latest filing 2018-02-22 Regulatory Filings
Country AU Australia
Listing ASX MEM

About MEMPHASYS LIMITED.

https://www.memphasys.com/

Memphasys Limited is a biotechnology company specializing in the development of advanced cell separation and reproductive biotechnology solutions. The company's core technology platform utilizes proprietary membranes and electrophoresis to isolate high-quality cells from biological fluids. Its flagship product, the Felix™ system, is an automated device designed for the rapid separation of high-quality sperm from semen samples for use in human assisted reproductive technology (ART) procedures. This technology aims to improve clinical outcomes by selecting sperm with lower DNA fragmentation and higher motility compared to traditional centrifuge-based techniques. Beyond human fertility, the company applies its bio-separation expertise to animal health, including diagnostic tools for stallion fertility. Memphasys focuses on providing innovative solutions that enhance efficiency and success rates in the global reproductive health market.

Recent filings

Filing Released Lang Actions
Appendix 4D - December 2017 Half year Financial Accounts 23 pages 980.7KB
Regulatory Filings
2018-02-22 English
Commercialisation Progress of Felix Device 23 pages 917.3KB
Regulatory Filings
2018-02-21 English
Legal action with Platinum Road / Bridge Road Capital 1
Regulatory Filings
2018-02-12 English
Appendix 3B 13 pages 562.9KB
Regulatory Filings
2018-01-01 English
Placement s708 cleansing notice 1 page 399.2KB
Regulatory Filings
2018-01-01 English
Appendix 3B Placement 13 pages 728.5KB
Regulatory Filings
2017-12-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.